Cardiovascular disease is one of the leading causes of mortality and morbidity worldwide. Atherosclerosis imaging has traditionally focused on detection of obstructive luminal stenoses or measurements of plaque burden. However, with advances in imaging technology it has now become possible to noninvasively interrogate plaque composition and disease activity, thereby differentiating stable from unstable patterns of disease and potentially improving risk stratification. This manuscript reviews multimodality imaging in this field, focusing on carotid and coronary atherosclerosis and how these novel techniques have the potential to complement current imaging assessments and improve clinical decision making.
C ardiovascular disease remains the leading cause of death globally, placing a major burden on health care services worldwide (1) . Atherosclerosis is the main pathophysiological process responsible for ischemic heart disease and cerebrovascular disease. It is a systemic, multifocal process that starts early in life with a long quiescent phase before the manifestation of overt disease
(2) and symptoms that vary depending on the morphology and characteristics of the underlying plaque. Obstructive atherosclerotic disease in the coronary arteries leads to the development of myocardial ischemia and angina and is usually characterized by stable plaque. Alternatively, unstable atherosclerotic plaque is prone to abrupt rupture or erosion, which is often clinically silent but can result in thrombotic vessel occlusion and acute stroke or myocardial infarction (MI).
Modern imaging techniques now allow for the direct and noninvasive imaging of atherosclerotic plaque in the carotid and coronary arteries, for the first time facilitating the assessment of plaque composition and disease activity (Central Illustration).
In this review we discuss how these novel approaches 
CURRENT IMAGING STRATEGIES
The clinical approach to atherosclerosis imaging has for many decades been based around the detection of obstructive luminal stenoses and the clinical sequelae that can ensue. In the carotid arteries the degree of luminal stenosis, assessed by ultrasound, coronary computed tomography angiography (CTA), or magnetic resonance (MR) angiography, is routinely used to inform decisions regarding surgical revascularization (4) .
However, a significant number of strokes occur in patients with nonobstructive carotid plaque. Indeed, the presence of a severe stenosis provides only modest risk prediction of future events, particularly in asymptomatic individuals (5) . In the coronary arteries, CTA can directly assess luminal stenosis severity aided by the functional assessment provided by computed tomography (CT) fractional flow reserve, whereas myocardial stress perfusion imaging and stress echocardiography detect the myocardial consequences of obstructive plaques.
However, although stable angina and symptoms of cardiac ischemia are associated with severe coronary artery stenoses, most MIs occur at sites of nonobstructive plaque on antecedent angiography (6) .
These findings, coupled with the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) and BARI-2D (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trials (7, 8) in which percutaneous coronary intervention failed to reduce the risk of MI despite effective relief of ischemia, suggest that the relationship between obstructive stenoses, myocardial ischemia, and adverse outcomes may not be causal. Consequently, there has been significant interest in alternative imaging strategies targeting different aspects of the atherosclerotic disease process.
One such strategy has been to quantify the total atherosclerotic plaque burden, the rationale being that the more plaques a patient has, the more likely it is that a plaque rupture will occur and cause a clinical event.
Indeed, regardless of the specific modality used, all imaging measures of atherosclerotic plaque burden seem to provide powerful prognostic information (9, 10) . In the carotid arteries, ultrasound-derived plaque burden assessments improve risk prediction beyond that provided by cardiovascular risk scores (11, 12) . In the coronary arteries, CT calcium scoring quantifies macroscopic deposits of calcification and provides a surrogate of total coronary atherosclerotic burden. This technique offers powerful prognostication of incremental value to cardiovascular risk scores.
The relationship between calcium score and major adverse cardiovascular events including all-cause mortality, cardiovascular events, and non-fatal MI has been established in several studies (13, 14) . A large observational study involving 25,253 patients in the United States with a mean follow-up of 6.8 years showed that survival varied significantly by the extent of coronary artery calcification (CAC) (p < 0.0001) with survival rates of 99.4%, 94.7%, and 87.8%, respectively, for CAC scores of 0, 400 to 699, and $1,000 (p < 0.0001) (13) . There have been multiple studies examining the very low event rates in patients with CAC of zero (15, 16 Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease -2 0 1 9 : --extensive lipid deposition, foam cell formation, and vascular smooth muscle cells migration (17 approximately 90% of ischemic strokes (19) . sound is difficult to perform (31) . Many of the adverse plaque characteristics that can be identified in the coronaries (discussed next) can also be assessed in the carotids. However, this approach requires radiation and iodinated contrast and is less sensitive and specific than MR angiography, which is therefore usually preferred (32) .
MR is well suited to atherosclerotic plaque characterization given the soft tissue contrast it provides. Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease -2 0 1 9 : --increased uptake in culprit carotid plaques following stroke, independent of vessel stenosis, and correlated with inflammatory cell burden on histology (55) . In patients with carotid disease, 11 
THE CORONARY ARTERIES
Ischemic heart disease is the most common global cause of death (28) . There is consequently a major focus on primary and secondary prevention, with an attendant need to accurately identify patients who might benefit from preventative therapies. As in the carotids, there is interest in using advanced imaging to differentiate stable coronary atheroma from the unstable patterns of disease associated with plaque rupture and clinical events. However, these approaches are considerably more challenging in the small-caliber, highly mobile coronary arteries (62 When these trials were considered as part of a metaanalysis again CT was associated with a reduction in MI, although there was no difference in mortality (66) . It is important to note that in both trials roughly one-half of the observed MIs occurred in patients with nonobstructive disease on their baseline scan (63) . Indeed, the value of CT imaging probably lies in its ability to identify obstructive and nonobstructive plaque and to provide an overall assessment of plaque burden. On the back of this growing clinical adoption the next step is to assess whether CT or hybrid assessments of plaque type can further refine patient assessment (67, 68 Secondary analyses exploring the associations between adverse plaque characteristics and outcomes have been performed in both the PROMISE and SCOT-HEART cohorts. The PROMISE data showed that even after adjusting for risk factors and stenosis severity, the presence of adverse plaque features is associated with an increased risk of major adverse cardiac events (HR: 1.72; 95% CI: 1.89 to 3.93), with stronger associations observed in younger patients, those with nonobstructive disease, and women (67) . This is consistent with the SCOT-HEART data that demonstrated a 3-fold increase in events in patients with adverse plaque (positive remodeling or lowattenuation plaque) (68) . The presence of both obstructive disease and adverse plaque had a synergistic effect with a resultant 10-fold increase in these patients compared with those with normal coronary arteries (68) . Importantly, however, the predictive effect of adverse plaque features and obstructive disease was not significant when adjusted for calcium score, which emerged as the only independent predictor of fatal or nonfatal MI. Although these data support the hypothesis that patients with adverse (Figure 4) , and that the presence of such high-intensity coronary plaque identifies patients at increased future risk of cardiovascular events (86) . This approach is deserving of further study. Localizes to culprit coronary and carotid plaque (53) . No physiological uptake in the myocardium.
In some cases lack of availability limits its use even in research. Further validation studies are needed. 11 
HIGHLIGHTS
Assessment of coronary and carotid atherosclerotic plaque composition is possible using computed tomography and magnetic resonance imaging.
Disease activity in coronary and carotid atherosclerotic plaque can be assessed using molecular imaging techniques, such as positron emission tomography.
These imaging assessments of plaque type can be used to differentiate stable from unstable patterns of atherosclerosis and potentially to improve patient risk stratification. Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease -2 0 1 9 : ---
